Breaking News

U.S. Legislation Seeking Sanctions on BGI, WuXi Apptec Advances

U.S. homeland security committee voted 11-1 to move draft legislation forward to approve a bill that could restrict business with Chinese biotechs.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

On March 6th, legislation that aims to prevent foreign adversaries from stealing sensitive American genetic data and personal health information advanced in the Senate. The U.S. homeland security committee voted 11-1 to move draft legislation forward to approve a bill that could restrict business with Chinese biotech companies, such as BGI Group and WuXi AppTec, citing serious national security risk posed due to their significant ties to the Chinese Communist Party.   The bill would need to pa...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters